serw-MX  [xml]  
 
    
 DeCS Categories

C05 Musculoskeletal Diseases .
C05.651 Muscular Diseases .
C10 Nervous System Diseases .
C10.668 Neuromuscular Diseases .
C10.668.491 Muscular Diseases .
C10.668.758 Neuromuscular Junction Diseases .
C10.720 Neurotoxicity Syndromes .
C25 Chemically-Induced Disorders .
C25.723 Poisoning .
C25.723.705 Neurotoxicity Syndromes .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.663 Peripheral Nervous System Agents .
D27.505.696.663.700 Neuromuscular Agents .
E03 Anesthesia and Analgesia .
E03.706 Neuromuscular Blockade .
E05 Investigative Techniques .
E05.635 Neuromuscular Blockade .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
Neuromuscular Diseases .
Cramp-Fasciculation Syndrome .
Fasciculation-Cramp Syndrome, Benign .
Foley-Denny-Brown Syndrome .
Oppenheim's Disease .
Benign Fasciculation-Cramp Syndrome .
Benign Fasciculation-Cramp Syndromes .
Cramp Fasciculation Syndrome .
Cramp-Fasciculation Syndromes .
Fasciculation Cramp Syndrome, Benign .
Fasciculation-Cramp Syndromes, Benign .
Foley Denny Brown Syndrome .
Neuromuscular Disease .
Oppenheims Disease .
Syndrome, Cramp-Fasciculation .
Syndrome, Foley-Denny-Brown .
Syndromes, Cramp-Fasciculation .
Amyotonia Congenita .
Oppenheim Disease .
MYATONIA CONGENITA .
OPPENHEIM'S DISEASE .
A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA. .
1.00
 
Neuromuscular Junction Diseases .
Neuromuscular Junction Disorders .
Neuromuscular Junction Toxic Disorders .
Neuromuscular Transmission Disorders .
Toxic Disorders, Neuromuscular Junction .
Neuromuscular Junction Disease .
Neuromuscular Junction Disorder .
Neuromuscular Transmission Disorder .
Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions. .
0.75
1185
 
Neurotoxicity Syndromes .
Encephalopathy, Toxic .
Nervous System Poisoning .
Neurotoxic Disorders .
Neurotoxin Diseases .
Neurotoxin Disorders .
Toxic Encephalitis .
Encephalitides, Toxic .
Encephalitis, Toxic .
Encephalopathies, Toxic .
Nervous System Poisonings .
Neurotoxic Disorder .
Neurotoxicity Syndrome .
Neurotoxin Disease .
Neurotoxin Disorder .
Poisonings, Nervous System .
Syndrome, Neurotoxicity .
Syndromes, Neurotoxicity .
Toxic Encephalitides .
Toxic Encephalopathies .
Toxic Encephalopathy .
Poisoning, Nervous System .
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents. .
0.68
654182
 
Neuromuscular Agents .
Neuromuscular Effect .
Neuromuscular Effects .
Agents, Neuromuscular .
Effect, Neuromuscular .
Effects, Neuromuscular .
Muscle Relaxants, Skeletal .
Relaxants, Skeletal Muscle .
Skeletal Muscle Relaxants .
Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS. .
0.65
1174939
 
Muscular Diseases .
Myopathic Conditions .
Muscle Disorder .
Muscular Disease .
Myopathic Condition .
Myopathy .
Muscle Disorders .
Myopathies .
Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. .
0.65
33720488
 
Neuromuscular Blockade .
Neuromuscular Block .
Block, Neuromuscular .
Blockade, Neuromuscular .
The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here. .
0.63
1151845